Literature DB >> 27681703

Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.

Takashi Okamura1, Yasuyo Nakajima, Akiko Katano-Toki, Kazuhiko Horiguchi, Shunichi Matsumoto, Satoshi Yoshino, Eijiro Yamada, Takuya Tomaru, Sumiyasu Ishii, Tsugumichi Saito, Atsushi Ozawa, Nobuyuki Shibusawa, Tetsurou Satoh, Shuichi Okada, Rin Nagaoka, Daisuke Takada, Jun Horiguchi, Tetsunari Oyama, Masanobu Yamada.   

Abstract

Somatic mutations in KCNJ5 gene have been identified in patients with adrenal aldosterone-producing adenomas (APAs). We previously reported that Japanese patients with APAs had distinct characteristics from patients in Western countries; i.e. they had a high frequency of KCNJ5 mutations and exhibited a frequent association with cortisol co-secretion. Therefore, APAs among Japanese patients may have different features from those in Western countries. We added recent cases, examined 47 cases (43% male) of APAs, including clinicopathological features, KCNJ5 mutations, and the mRNA levels of several steroidogenic enzymes, and compared the results obtained to those reported in other countries. While the prevalence of KCNJ5 mutations is approximately 40% in Western countries, 37 APA cases (78.7%) showed mutations: 26 with p.G151R and 11 with p.L168R. Although a significant gender difference has been reported in the frequency of KCNJ5 mutations in Europe, we did not find any gender difference. However, the phenotypes of Japanese patients with mutations were similar to those of patients in Western countries; patients were younger and had higher plasma aldosterone levels, lower potassium levels, and higher diastolic blood pressure. Reflecting these phenotypes, APAs with mutations had higher CYP11B2 mRNA levels. However, in contrast to APAs in Western countries, Japanese APAs with mutations showed lower CYP11B1, CYP17A1, and CYP11A1 mRNA levels. These findings demonstrated that Japanese APA patients may have distinct features including a higher prevalence of KCNJ5 mutations, no gender difference in the frequency of these mutations, and characteristics similar to the zona glomerulosa.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27681703     DOI: 10.1507/endocrj.EJ16-0243

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  12 in total

Review 1.  Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm.

Authors:  Michael R Lattanzio; Matthew R Weir
Journal:  Kidney360       Date:  2020-07-23

Review 2.  Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.

Authors:  Georgia Pitsava; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Curr Cardiol Rep       Date:  2022-07-16       Impact factor: 3.955

Review 3.  Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas.

Authors:  Juilee Rege; Adina F Turcu; William E Rainey
Journal:  Gland Surg       Date:  2020-02

4.  Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.

Authors:  Zeng Guo; Kazutaka Nanba; Aaron Udager; Brett C McWhinney; Jacobus P J Ungerer; Martin Wolley; Moe Thuzar; Richard D Gordon; William E Rainey; Michael Stowasser
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 5.  GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Eur J Endocrinol       Date:  2021-05-21       Impact factor: 6.664

6.  A Novel Case of Somatic KCNJ5 Mutation in Pediatric-Onset Aldosterone-Producing Adenoma.

Authors:  Noboru Uchida; Naoko Amano; Yui Yamaoka; Ayumi Uematsu; Yuji Sekine; Makoto Suzuki; Jun Watanabe; Koshiro Nishimoto; Kuniaki Mukai; Ryuji Fukuzawa; Tomonobu Hasegawa; Tomohiro Ishii
Journal:  J Endocr Soc       Date:  2017-07-11

7.  Prevalence and Histopathological Characteristics of KCNJ5 Mutant Aldosterone-Producing Adenomas in a Multi-Ethnic Malaysian Cohort.

Authors:  Syahirah Kaja Mohideen; Muaatamarulain Mustangin; Nor Azmi Kamaruddin; Rohaizak Muhammad; A Rahman A Jamal; Norlela Sukor; Geok Chin Tan; Elena Aisha Azizan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-04       Impact factor: 5.555

8.  Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.

Authors:  Kazutaka Nanba; Yuto Yamazaki; Nolan Bick; Kei Onodera; Yuta Tezuka; Kei Omata; Yoshikiyo Ono; Amy R Blinder; Scott A Tomlins; William E Rainey; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

9.  The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.

Authors:  Taweesak Wannachalee; Elaine Caoili; Kazutaka Nanba; Aya Nanba; William E Rainey; James J Shields; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

10.  Age-Dependent Progression of Renal Dysfunction After Adrenalectomy for Aldosterone-Producing Adenomas in Japan.

Authors:  Masayuki Yoshioka; Yasuyo Nakajima; Tomoko Miyamoto; Takamichi Igarashi; Koji Sakamaki; Masako Akuzawa; Emi Ishida; Kazuhiko Horiguchi; Eijiro Yamada; Tsugumichi Saito; Atsushi Ozawa; Younosuke Shimomura; Isao Kobayashi; Yoshitaka Andou; Ken Shirabe; Masanobu Yamada
Journal:  J Endocr Soc       Date:  2018-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.